Search Results - Anne Robinson

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
    Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease

    Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease by Jean‐Frédéric Colombel, Brian G. Feagan, William J. Sandborn, Gert Van Assche, Anne Robinson

    Published 2011
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from <scp>CHARM</scp> and <scp>ADHERE</scp>

    Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from <scp>CHARM</scp> and <scp>ADHERE</scp> by Remo Panaccione, J F Colombel, William J. Sandborn, Geert D’Haens, Qian Zhou, P Pollack, Roopal Thakkar, Anne Robinson

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Serum Adalimumab Concentration and Clinical Remission in Patients with Crohnʼs Disease

    Serum Adalimumab Concentration and Clinical Remission in Patients with Crohnʼs Disease by Yi‐Lin Chiu, David T. Rubin, Séverine Vermeire, Édouard Louis, Anne Robinson, Kathleen G. Lomax, Paul F. Pollack, Susan K. Paulson

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Pharmacokinetics and Exposure–Efficacy Relationship of Adalimumab in Pediatric Patients with Moderate to Severe Crohnʼs Disease

    Pharmacokinetics and Exposure–Efficacy Relationship of Adalimumab in Pediatric Patients with Moderate to Severe Crohnʼs Disease by Shringi Sharma, Doerthe Eckert, Jeffrey S. Hyams, Sven Mensing, Roopal Thakkar, Anne Robinson, Joel R. Rosh, Frank M. Ruemmele, Walid M. Awni

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease

    Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease by Mark T. Osterman, William J. Sandborn, Jean–Frédéric Colombel, Anne Robinson, Winnie Lau, Bidan Huang, Paul F. Pollack, Roopal Thakkar, James D. Lewis

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease

    Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease by Stefanie Schreiber, Walter Reinisch, J F Colombel, William J. Sandborn, Daniël W. Hommes, Anne Robinson, B Huang, Kathleen G. Lomax, P Pollack

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

    Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis by Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, Takayuki Matsumoto, Toshifumi Hibi∥, Anne Robinson, Nael M. Mostafa, Jingdong Chao, Vipin Arora, Anne Camez, Roopal Thakkar, Mamoru Watanabe

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy

    Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventiona... by J F Colombel, Bindia Jharap, William J. Sandborn, Brian G. Feagan, Laurent Peyrin–Biroulet, Samantha Eichner, Anne Robinson, Nael M. Mostafa, Qian Zhou, Roopal Thakkar

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    One‐year maintenance outcomes among patients with moderately‐to‐severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2

    One‐year maintenance outcomes among patients with moderately‐to‐severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA... by William J. Sandborn, J F Colombel, Geert D’Haens, Gert Van Assche, Douglas C. Wolf, Martina Kron, A. Lazar, Anne Robinson, Mei Yang, J. Chao, Roopal Thakkar

    Published 2012
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn’s Disease: Results from the EXTEND Trial

    Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn’s Disease: Results from the EXTEND Trial by Walter Reinisch, Jean‐Frédéric Colombel, Geert D’Haens, William J. Sandborn, Paul Rutgeerts, Karel Geboes, Joel Petersson, Samantha Eichner, Qian Zhou, Anne Robinson, Holly A. Read, Roopal Thakkar

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohnʼs Disease

    Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohnʼs Disease by William A. Faubion, Marla C. Dubinsky, Frank M. Ruemmele, Johanna C. Escher, Joel R. Rosh, Jeffrey S. Hyams, Samantha Eichner, Yao Li, Nattanan Reilly, Roopal Thakkar, Anne Robinson, Andreas Lazar

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3

    Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3 by Jean–Frédéric Colombel, William J. Sandborn, Subrata Ghosh, Douglas C. Wolf, Remo Panaccione, Brian G. Feagan, Walter Reinisch, Anne Robinson, Andreas Lazar, Martina Kron, Bidan Huang, Martha Skup, Roopal Thakkar

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA

    Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA by Simon Travis, Brian G. Feagan, Laurent Peyrin–Biroulet, Remo Panaccione, Silvio Danese, Andreas Lazar, Anne Robinson, Joel Petersson, Brandee Pappalardo, Mareike Bereswill, Naijun Chen, Song Wang, Martha Skup, Roopal Thakkar, Jingdong Chao

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Adalimumab for the Treatment of Japanese Patients With Intestinal Behçet’s Disease

    Adalimumab for the Treatment of Japanese Patients With Intestinal Behçet’s Disease by Satoshi Tanida, Nagamu Inoue, Kiyonori Kobayashi, Makoto Naganuma, Fumihito Hirai, Bunei Iizuka, Kenji Watanabe, Keiichi Mitsuyama, Takuya Inoue, Yoshiaki Ishigatsubo, Yasuo Suzuki, Masakazu Nagahori, Satoshi Motoya, Shirô Nakamura, Vipin Arora, Anne Robinson, Roopal Thakkar, Toshifumi Hibi∥

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis

    Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis by Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch, Laurent Peyrin–Biroulet, Remo Panaccione, P. Rutgeerts, Stephen B. Hanauer, Subrata Ghosh, Gert Van Assche, Anne Robinson, Winnie Lau, J. Maa, B Huang, Brandee Pappalardo, Holly A. Read

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results

    Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results by Geert D’Haens, William J. Sandborn, Edward V. Loftus, Stephen B. Hanauer, Stefan Schreiber, Laurent Peyrin–Biroulet, Remo Panaccione, Julián Panés, Filip Baert, Jean‐Frédéric Colombel, Marc Ferrante, Édouard Louis, Alessandro Armuzzi, Qian Zhou, Venkata Sasikiran Goteti, Nael M. Mostafa, Thao Doan, Joel Petersson, Tricia Finney‐Hayward, Alexandra Song, Anne Robinson, Silvio Danese

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

    Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial by Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukáš, Filip Baert, Tomáš Vaňásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, Walter Reinisch, William J. Sandborn, Paul Rutgeerts, Daniël W. Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Paloma Méndez, Joel Petersson, Kori Wallace, Anne Robinson, Roopal Thakkar, Geert D’Haens

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study

    Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study by Brian G. Feagan, Julián Panés, Marc Ferrante, Arthur Kaser, Geert D’Haens, William J. Sandborn, Édouard Louis, Markus F. Neurath, Denis Franchimont, Olivier Dewit, Ursula Seidler, Kyung-Jo Kim, Christian P. Selinger, Steven J. Padula, Ivona Herichova, Anne Robinson, Kori Wallace, Jun Zhao, Mukul Minocha, Mohamed I. A. Othman, Adina Soaita, Sudha Visvanathan, David B. Hall, Wulf O. Böcher

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results

    Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results by Julián Panés, Jean‐Frédéric Colombel, Geert D’Haens, Stefan Schreiber, Remo Panaccione, Laurent Peyrin–Biroulet, Edward V. Loftus, Silvio Danese, Satoshi Tanida, Yusuke Okuyama, Édouard Louis, Alessandro Armuzzi, Marc Ferrante, Harald Vogelsang, Toshifumi Hibi∥, Mamoru Watanabe, J Lefèbvre, Tricia Finney‐Hayward, Yuri Sánchez González, Thao Doan, Nael M. Mostafa, Kimitoshi Ikeda, Wangang Xie, Bidan Huang, Joel Petersson, Jasmina Kalabic, Anne Robinson, William J. Sandborn

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Association of Implementation of Practice Standards for Electrocardiographic Monitoring With Nurses’ Knowledge, Quality of Care, and Patient Outcomes

    Association of Implementation of Practice Standards for Electrocardiographic Monitoring With Nurses’ Knowledge, Quality of Care, and Patient Outcomes by Marjorie Funk, Kristopher P. Fennie, Kimberly E. Stephens, Jeanine May, Catherine Winkler, Barbara J. Drew, Barbara Borman, Stephanie Calcasola, Mary G. Carey, L. Currie, Leslie L. Davis, Eleanor Fitzpatrick, Rhonda Fleischman, Darice Hawkins, Elise Hazlewood, Rebecca Henry, Cindy Honess, Peggy Kalowes, Sharon Ann Kearns, Bobbi Leeper, Joseph Liggett, Paula Lusardi, Carol Lynn, Manbo Man, Kathleen McCauley, M. Hing, Anita Pang, Janet Parkosewich, JoAnne Phillips, Anne Robinson, Noraliza Salazar, Kristin E. Sandau, Cass Piper Sandoval, Prasama Sangkachand, Rose B. Shaffer, Heather Sherrard, Maureen Smith, Rebecca Stamm, Vickie Strang, Nancy Wen Sim Tee, K. J. Wells, Paula White

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: